Literature DB >> 19819948

Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules.

Martha E Cruz-Soto1, Gabriela Cosío, Michael C Jeziorski, Víctor Vargas-Barroso, Manuel B Aguilar, Alfonso Cárabez, Peter Berger, Paul Saftig, Edith Arnold, Stéphanie Thebault, Gonzalo Martínez de la Escalera, Carmen Clapp.   

Abstract

Vasoinhibins are a family of N-terminal prolactin (PRL) fragments that inhibit blood vessel growth, dilation, permeability, and survival. The aspartyl endoprotease cathepsin D is active at acidic pH and can cleave rat PRL to generate vasoinhibins. We investigated whether and where vasoinhibins could be generated by cathepsin D in the adenohypophysis of rats and mice and whether their production could be gender dependent. Vasoinhibins were detected in primary cultures of rat adenohypophyseal cells by Western blot with antibodies directed against the N terminus of PRL but not the C terminus. Ovariectomized, estrogen-treated females show greater levels of adenohypophyseal vasoinhibins than males. Peptide sequencing analysis revealed that the cleaved form of PRL in rat adenohypophyseal extracts contains the PRL N terminus and a second N terminus starting at Ser(149), the reported cleavage site of cathepsin D in rat PRL. In addition, cathepsin D inhibition by pepstatin A reduced vasoinhibin levels in rat adenohypophyseal cell cultures. Confocal and electron microscopy showed the colocalization of cathepsin D and PRL within rat adenohypophyseal cells and secretory granules, and a subcellular fraction of rat adenohypophysis enriched in secretory granules contained cathepsin D activity able to generate vasoinhibins from PRL. Of note, vasoinhibins were absent in the adenohypophysis of mice lacking the cathepsin D gene but not in wild-type mice. These findings show that cathepsin D is the main protease responsible for the generation of adenohypophyseal vasoinhibins and that its action can take place within the secretory granules of lactotrophs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819948     DOI: 10.1210/en.2009-0390

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Minireview: Extrapituitary prolactin: an update on the distribution, regulation, and functions.

Authors:  Robert J Marano; Nira Ben-Jonathan
Journal:  Mol Endocrinol       Date:  2014-04-02

Review 2.  Pathophysiology and risk factors of peripartum cardiomyopathy.

Authors:  Martijn F Hoes; Zoltan Arany; Johann Bauersachs; Denise Hilfiker-Kleiner; Mark C Petrie; Karen Sliwa; Peter van der Meer
Journal:  Nat Rev Cardiol       Date:  2022-01-11       Impact factor: 49.421

3.  Lowering Endogenous Cathepsin D Abundance Results in Reactive Oxygen Species Accumulation and Cell Senescence.

Authors:  Siyuan Su; Xu Zhu; Liang Lin; Xianwei Chen; Yang Wang; Jin Zi; Yusheng Dong; Yingying Xie; Yinghui Zhu; Ju Zhang; Jianhui Zhu; Dan Xu; Ningzhi Xu; Xiaomin Lou; Siqi Liu
Journal:  Mol Cell Proteomics       Date:  2015-12-10       Impact factor: 5.911

4.  N-terminal prolactin-derived fragments, vasoinhibins, are proapoptoptic and antiproliferative in the anterior pituitary.

Authors:  Jimena Ferraris; Daniela Betiana Radl; Sandra Zárate; Gabriela Jaita; Guadalupe Eijo; Verónica Zaldivar; Carmen Clapp; Adriana Seilicovich; Daniel Pisera
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

Review 5.  Principles of the prolactin/vasoinhibin axis.

Authors:  Jakob Triebel; Thomas Bertsch; Cornelius Bollheimer; Daniel Rios-Barrera; Christy F Pearce; Michael Hüfner; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-26       Impact factor: 3.619

Review 6.  From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.

Authors:  Jakob Triebel; Maria Ludivina Robles-Osorio; Renata Garcia-Franco; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-11       Impact factor: 5.555

7.  Development of Vasoinhibin-Specific Monoclonal Antibodies.

Authors:  Nils Müller; Juan Pablo Robles; Magdalena Zamora; Johannes Ebnet; Hülya Markl-Hahn; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch; Jakob Triebel
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-20       Impact factor: 5.555

8.  Human Placental Tissue Contains A Placental Lactogen-Derived Vasoinhibin.

Authors:  Hülya Markl-Hahn; Leon Neugebauer; Livia Lenke; Sarah Ecker; Tamara Merz; Oscar McCook; Noura Khoder; Cosima Brucker; Peter Radermacher; Christiane Waller; Carmen Clapp; Thomas Bertsch; Jakob Triebel
Journal:  J Endocr Soc       Date:  2022-02-20

9.  Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.

Authors:  Jakob Triebel; Christin J Friedrich; Andreas Leuchs; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-06       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.